SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-23-214311
Filing Date
2023-08-16
Accepted
2023-08-16 16:08:42
Documents
56
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 6-K d511743d6k.htm   iXBRL 6-K 77476
2 EX-99.1 d511743dex991.htm   iXBRL EX-99.1 627272
3 EX-99.2 d511743dex992.htm EX-99.2 97509
4 EX-99.3 d511743dex993.htm EX-99.3 93797
  Complete submission text file 0001193125-23-214311.txt   3454964

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA ncna-20230630.xsd EX-101.SCH 31971
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ncna-20230630_cal.xml EX-101.CAL 37548
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ncna-20230630_def.xml EX-101.DEF 79600
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE ncna-20230630_lab.xml EX-101.LAB 208469
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ncna-20230630_pre.xml EX-101.PRE 167204
50 EXTRACTED XBRL INSTANCE DOCUMENT d511743d6k_htm.xml XML 579739
Mailing Address 3 LOCHSIDE WAY EDINBURGH X0 EH12 9DT
Business Address 3 LOCHSIDE WAY EDINBURGH X0 EH12 9DT 44-0-131-357-1111
NuCana plc (Filer) CIK: 0001709626 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38215 | Film No.: 231178295
SIC: 2834 Pharmaceutical Preparations